Christiaan De Wilde

Fujirebio and H.U. Group Holdings Launch Quantitative NfL Assays for Research Use Only

(IN BRIEF) H.U. Group Holdings Inc. and Fujirebio have announced the launch of Lumipulse G NfL CSF and Lumipulse G…

1 year ago

OHMX.bio and Fujirebio Europe to develop clinical in vitro diagnostics platform incorporating third generation sequencing technologies

IVD-seq project received 720K EURO research grant from Flanders Innovation & Entrepreneurship (VLAIO) (PRESS RELEASE) GENT, 8-Dec-2020 — /EuropaWire/ —…

3 years ago